TickerFactsScreenerDevelopers

RESMED INC (RMD) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2008: $321.08M2009: $415.65M2010: $488.78M2011: $735.27M2012: $809.54M2013: $876.05M2014: $905.73M2015: $717.25M2016: $731.43M2017: $821.93M2018: $188.70M2019: $147.13M2020: $463.16M2021: $295.28M2022: $273.71M2023: $227.89M2024: $238.36M2025: $1.21B$1.21B
2008Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$1.21B+407.4%
2024$238.36M+4.6%
2023$227.89M-16.7%
2022$273.71M-7.3%
2021$295.28M-36.2%
2020$463.16M+214.8%
2019$147.13M-22.0%
2018$188.70M-77.0%
2017$821.93M+12.4%
2016$731.43M+2.0%
2015$717.25M-20.8%
2014$905.73M+3.4%
2013$876.05M+8.2%
2012$809.54M+10.1%
2011$735.27M+50.4%
2010$488.78M+17.6%
2009$415.65M+29.5%
2008$321.08M—